Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiglutamatergic Treatment of Bulimia Nervosa and Body Dysmorphic Disorder: An Open-Label Trial of Memantine

NCT01038128 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT01038128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01038128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiglutamatergic Treatment of Bulimia Nervosa and Body Dysmorphic Disorder: An Open-Label Trial of Memantine
Lead sponsor
Mclean Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2009
Completion date
May 31, 2011
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body dysmorphic disorder, bulimia nervosa